KILSTRUP-NIELSEN, CHARLOTTE
 Distribuzione geografica
Continente #
NA - Nord America 5.982
EU - Europa 3.497
AS - Asia 2.415
SA - Sud America 222
AF - Africa 51
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 12.197
Nazione #
US - Stati Uniti d'America 5.911
IT - Italia 1.688
SG - Singapore 812
CN - Cina 564
UA - Ucraina 526
VN - Vietnam 357
DE - Germania 250
HK - Hong Kong 250
TR - Turchia 247
SE - Svezia 227
BR - Brasile 185
FI - Finlandia 182
IE - Irlanda 149
GB - Regno Unito 134
FR - Francia 132
RU - Federazione Russa 80
IN - India 43
JP - Giappone 43
BD - Bangladesh 30
CA - Canada 30
MX - Messico 28
AU - Australia 26
NL - Olanda 24
GH - Ghana 21
BE - Belgio 20
PL - Polonia 19
ES - Italia 18
AR - Argentina 15
AT - Austria 12
IR - Iran 12
ZA - Sudafrica 10
CZ - Repubblica Ceca 8
IQ - Iraq 8
UZ - Uzbekistan 7
EC - Ecuador 5
ID - Indonesia 5
MA - Marocco 5
PH - Filippine 5
CL - Cile 4
CO - Colombia 4
EG - Egitto 4
JM - Giamaica 4
PT - Portogallo 4
TN - Tunisia 4
DK - Danimarca 3
EU - Europa 3
IL - Israele 3
JO - Giordania 3
KR - Corea 3
MD - Moldavia 3
MY - Malesia 3
NG - Nigeria 3
PK - Pakistan 3
RO - Romania 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
UY - Uruguay 2
VE - Venezuela 2
AQ - Antartide 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GA - Gabon 1
GY - Guiana 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 12.197
Città #
Milan 1.082
Fairfield 473
Singapore 448
San Jose 437
Chandler 431
Ashburn 430
Jacksonville 403
Woodbridge 358
Houston 339
Hong Kong 244
Ann Arbor 243
Dearborn 233
Seattle 212
Wilmington 188
Beijing 182
Cambridge 168
Dallas 164
Dublin 149
Princeton 147
Como 131
The Dalles 128
Izmir 111
Chicago 110
New York 109
Nyköping 105
Dong Ket 92
Boardman 89
Council Bluffs 86
Rome 81
Ho Chi Minh City 75
Lauterbourg 75
Los Angeles 74
Munich 59
San Mateo 41
Hanoi 40
Helsinki 38
Buffalo 37
Kocaeli 36
Santa Clara 36
Tokyo 32
London 30
Ogden 30
Orem 28
San Diego 27
Turku 25
Guangzhou 23
Brussels 19
São Paulo 19
Mexico City 18
Turin 18
Brooklyn 17
Chennai 17
Warsaw 17
Hefei 16
Nanjing 16
Washington 16
Kunming 14
Melbourne 14
Monza 14
Düsseldorf 13
Atlanta 12
Da Nang 12
Phoenix 12
Toronto 12
Accra 11
Amsterdam 11
Frankfurt am Main 11
Shanghai 11
Stockholm 11
Boston 10
Jinan 10
Magnago 10
Shenzhen 10
Verona 10
Denver 9
Gallarate 9
Vienna 9
Ankara 8
Mumbai 8
Norwalk 8
Nuremberg 8
Ponte Lambro 8
Poplar 8
Varese 8
West Jordan 8
Haiphong 7
Hangzhou 7
Redmond 7
Shenyang 7
Edinburgh 6
Johannesburg 6
Kilburn 6
Manchester 6
Montreal 6
Nanchang 6
Naples 6
Osaka 6
Rosdorf 6
Secaucus 6
Tashkent 6
Totale 8.645
Nome #
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 276
CDKL5 and shootin1 interact and concur in regulating neuronal polarization 263
MeCP2 related studies benefit from the use of CD1 as genetic background 238
Methyl-CpG binding protein 2 (MeCP2) localizes at the centrosome and is required for proper mitotic spindle organization 223
A novel protein, Xenopus p20, influences the stability of MeCP2 through direct interaction 221
Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action 219
The neurosteroid pregnenolone reverts microtubule derangement induced by the loss of a functional CDKL5-IQGAP1 complex 212
MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis? 211
CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail 210
CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome 209
CDKL5 localizes at the centrosome and midbody and is required for faithful cell division 206
Characterization of PREP2, a paralog of PREP1, which defines a novel sub-family of the MEINOX TALE homeodomain transcription factors 205
MeCP2 affects skeletal muscle growth and morphology through non cell-autonomous mechanisms 199
What We Know and Would Like to Know about CDKL5 and Its Involvement in Epileptic Encephalopathy. 191
CDKL5 influences RNA splicing activity by its association to the nuclear speckle molecular machinery. 188
Spatio-temporal dynamics and localization of MeCP2 and pathological mutants in living cells 187
A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain. 184
Synaptic synthesis, dephosphorylation and degradation: a novel paradigm for an activity-dependent neuronal control of CDKL5. 184
The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and HTH 183
Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation 181
Characterization of CDKL5 transcript isoforms in human and mouse 179
PBX1 nuclear export is regulated independently of PBX-MEINOX interaction by PKA phosphorylation of the PBC-B domain 176
Retinoic acid receptor a fusion to PML affects its transcriptional and chromatin-remodeling properties 175
The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5 175
Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms 171
The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis 170
CDKL5 ensures excitatory synapse stability by reinforcing NGL1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons 165
Brain phosphorylation of MeCP2 at serene 164 is developmentally regulated and globally alters its chromatin association 162
Methyl-CpG-binding protein 2 is phosphorylated by homeodomain-interacting protein kinase 2 and contributes to apoptosis 162
La cromatina e controllo dell'espressione genica. 161
The functional role of CDKL5 at the inhibitory synapse and its interaction with the cytoplasmatic collybistin-gephyrin complex 159
Characterization of HIPK2 that, by Associating with MeCP2, Might Function as a Modifier Gene in Rett Syndrome 158
A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision Medicine for the Treatment of Rett Syndrome. 158
Rescue of prepulse inhibition deficit and brain mitochondrial dysfunction by pharmacological stimulation of the central serotonin receptor 7 in a mouse model of CDKL5 Deficiency Disorder 155
CDKL5 belongs to the same molecular pathway of MeCP2 and is responsible for the early seizure variant of Rett Syndrome 153
Genetics and mechanisms of disease in Rett Syndrome 153
Extrasynaptic N-methyl-D-aspartate (NMDA) receptor stimulation induces cytoplasmic translocation of the CDKL5 kinase and its proteasomal degradation 153
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo 153
Loss of CDKL5 Causes Synaptic GABAergic Defects That Can Be Restored with the Neuroactive Steroid Pregnenolone-Methyl-Ether 151
Characterization of a novel MeCP2 interacting protein 151
DNA methylation and Rett syndrome 147
Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder? 147
Identification and Characterization of proteins that, interacting with MeCP2, could be involved in Rett Syndrome 145
MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders 145
CHARACTERIZATION OF THE CDKL5 GENE INVOLVED IN MENTAL RETARDATION AND INFANTILE SPASMS. 141
Spatio-temporal dynamics and localization of MeCP2 and pathological mutants in living cells 141
CDKL5 levels quickly respond to neuronal activity, reinforcing its involvement in synaptic plasticity 141
Identification and characterization of proteins that, interacting with MeCP2, could be involved in Rett Syndrome 141
2nd European Working Group on Rett Syndrome 138
Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency Disorder 138
Functional Characterization of CDKL5, a Novel Gene Involved in The Onset of Rett Syndrome and Infantile Spasms. 133
Characterization of HIPK2 that, by Associating with MeCP2, Might Function as a Modifier Gene in Rett Syndrome. 131
Characterization of the molecular mechanism underlying GABAA-receptor defects in CDKL5 deficiency disorder 129
Functional Characterization of CDKL5, an X-Linked Gene Involved in Mental Retardation and Epileptic Crisis. 129
Molecular characterization of CDKL5, a novel kinase involved in Rett syndrome and infantile spasms 125
Disruption of the Cellular Regulation of CDKL5 Might be Relevant for Rett Syndrome 124
Disruption of the Cellular Regulation of CDKL5 Might be Relevant for Rett Syndrome 123
DNA methylation in the control of gene silencing during development and human disorders (DisChrom) 122
Molecular characterization of CDKL5, a novel kinase involved in Rett syndrome and infantile spasms 121
Pregnenolone-methyl-ether enhances CLIP170 and microtubule functions improving spine maturation and hippocampal deficits related to CDKL5 deficiency 121
Functional characterization of CDKL5, a novel gene involved in Rett syndrome and infantile spams associated with mental retardation 118
Disruption of the Cellular Regulation of CDKL5 Might be Relevant for Rett Syndrome 117
Functional characterization of CDKL5, a novel gene involved in the onset of Rett Syndrome 117
Functional Characterization of CDKL5, a novel gene involved in the onset of Rett syndrome 116
European Working Group on Rett Syndrome 115
Therapeutic potential of pregnenolone and pregnenolone methyl ether on depressive and CDKL5 deficiency disorders: Focus on microtubule targeting 115
CDKL5 interacts with inhibitory postsynaptic scaffolding proteins and regulates synaptic GABAA receptor levels 114
Revealing a novel and unexpected function of MeCP2, possibly involved in RTT pathophysiology 112
Molecular characterization of the CDKL5 gene involved in mental retardation and infantile spams 110
Functional characterization of CDKL5, a novel gene involved in Rett Syndrome and infantile spams 109
Identification and characterization of proteins that interacting with MeCP2, could be involved in Rett Syndrome 108
Functional characterizationof CDKL5, a novel gene involved in the onset of Rett Syndrome 104
Molecular and functional characterization of CDKL5, a novel X-linked kinase, mainly involved in female mental retardation 103
The functional role of CDKL5 at the inhibitory synapse and its interaction with the cytoplasmatic collybistin-gephyrin complex 102
Molecular genetics of Rett syndrome: when epigenetic signals go unrecognized 101
Functional characterization of CDKL5, a novel kinase involved in Rett syndrome and infantile spasms 101
Cromatina e controllo dell'espressione genica 95
Novel role of CDKL5 in the inhibitory synapse and a possible therapeutic strategy for CDKL5-related defects 83
Identification and characterization of proteins that interacting with MECP2, could be involved in Rett Syndrome 82
The functional role of CDKL5 at the inhibitory synapse and its interaction with the cytoplasmatic collybistin-gephyrin complex 80
Rett syndrome: from the involved gene(s) to treatment 47
Totale 12.261
Categoria #
all - tutte 47.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 0 0 154
2021/2022669 87 92 50 33 23 21 26 32 36 100 80 89
2022/20231.082 107 82 56 114 70 227 9 149 131 38 50 49
2023/20241.829 282 261 293 289 322 181 20 47 59 29 12 34
2024/20251.318 7 38 238 36 93 72 55 34 161 117 148 319
2025/20263.253 268 203 170 420 305 257 659 201 356 193 147 74
Totale 12.261